The abstract is read at the publisher; the summary is JClub's.
Asplenia affects 17–20% of patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED), with cumulative risk approaching ~40% by age 40.
- Why it matters: The prevalence, timing, and mechanisms of APECED-associated asplenia are incompletely defined, limiting earlier recognition of a common IFN-γ–mediated complication.
- What they did: Two APECED cohorts (n=170) were followed with longitudinal imaging and peripheral blood smears, and selected patients underwent liver-spleen 99m Tc-sulfur colloid SC-SPECT/CT; AIRE-deficient mice were used to test IFN-γ dependence.
- The result: Splenic volume declined over years, PBS abnormalities appeared late, while SC-SPECT/CT detected impaired function earlier; in mice, splenic destruction was age-dependent, linked to increased IFN-γ activity, and prevented by Ifng ablation. Persistent leukocytosis and/or thrombocytosis occurred in 93.8% of asplenia patients and often preceded diagnosis by months to years.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.